Developer of natural cellular process of autophagy designed to open new target areas for drug discovery and development. The company's focus is on the autophagy system to improve the cellular process of clearing out unwanted proteins, organelles, and invading pathogens, it also arrests or reverses the progression of lysosomal storage disorders, muscle disorders, inflammatory disorders, and neurodegeneration, enabling physicians to address unmet medical needs and to bring cures to patients with serious diseases.
Developer of novel drug designed for doctors to treat neurodegenerative diseases. The company develops treatments that modulate mitophagy and autophagy by leveraging an understanding of critical neural pathways to discover and develop novel small molecules that will restore cellular balance and target lysosomes to modulate and restore their activity to prevent neurodegenerative diseases, enabling physicians to improve the lives of patients suffering from a range of neurodegenerative diseases and senescence.
Developer of next-generation controllable cell and gene therapies created to extend adoptive immunotherapy to every patient with cancer. The company's therapies are based on pharmacologic operating systems that provide exquisite control of protein activity in cells and create cell therapies with functions that are under the control of the treating physician using simple, safe, orally active, marketed drugs, enabling doctors to improve on the current generation of cell therapies.
Manufacturer and retailer of dietary supplements intended to sustainably improve and revolutionize the living environment, health and well-being of all and all future generations. The company offers energy drinks, test kits, cosmetics, animal feed as well as air purifiers, catering to all the healthcare and supplement needs of its customers from a single source and at a fair price.